Author

Fiorella Cañete 1

1 Hospital Universitari Germans Trias i Pujol,Gastroenterology,Badalona,Spain

EVALUATION OF ADHERENCE TO INFLIXIMAB THERAPY IN IBD PATIENTS

Ariadna Clos, GIANCARLO CORRALES ROMERO, Fiorella Cañete, Triana Lobaton Ortega, macarena larrain, Laura Marin, Miriam Mañosa, EDUARD CABRE, Eugeni Domenech Morral

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago García-López, Montserrat Andre

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago García-López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esth

THE AVAILABILITY OF INFLIXIMAB TROUGH LEVELS IN IBD PATIENTS ON MAINTENANCE THERAPY DEEPLY IMPACTS THERAPEUTIC DECISION-MAKING

Triana Lobaton Ortega, Fiorella Cañete, Aina Teniente, EDUARD CABRE, Miriam Mañosa, Eva Martinez, Eugeni Domenech Morral

RESCUE THERAPY WITH ANTI-TNF AGENTS FOR ESTABLISHED POST-OPERATIVE RECURRENCE OF CROHN'S DISEASE. A MULTICENTRE, RETROSPECTIVE, NATIONWIDE STUDY

Eugeni Domenech Morral, Fiorella Cañete, Miriam Mañosa, Ramiro Cruz Gonzalez Sueyro, Sabino Riestra Menéndez, Manuel Barreiro de Acosta, Pilar Nos, Eva Iglesias Flores, Ana Gutierrez Casbas, Raquel Ríos, Luis Bujanda Fernández de Piérola, Carlos Gonzalez Muñoza, Albert Villoria, María José Casanova González, Antonio García He

Clinical features, therapeutic requirements and evolution of patients with Crohn´s disease and upper digestive tract involvement (CROHNEX study)

Empar Sainz Arnau, Yamile Zabana, Isabel Miguel, Agnes Fernandez Clotet, Maria José Casanova, Maria Dolores Martín, Maria Dolores Picó, Erika Alfambra, Iago Rodríguez, Fernando Muñoz, Manuel Domínguez, Eva Iglesias, David Busquets, Ana Gutiérrez, Fiorella Cañete, Laura Núñez, Carlos Taxonera, Belen Beltran, Blau Camps, Xavier Calvet, Pablo Navarro, Margalida Calafat, Rocío Ferreiro-Iglesias, Carlos Gonzalez Muñoza, Beatriz Sicilia, Cristina Rodriguez, Ana Y. Carbajo, Manuel Van Domselaar, Raquel Vicente, Marta Piqueras, Mari Carmen Muñoz, Agueda Abad La Cruz, Alicia Algaba, Pilar Martinez, Milagros Vela, Beatriz Antolín, José María Huguet, Luis Bujanda, Rufo H. Lorente, Pedro Almela, Maria Jose Garcia, Patricia Ramírez de la Pirscina, Ramón Pajares, Isabel Pérez-Martínez, Alfredo J. Lucendo, Olga Merino, Jesús Legido, Isabel Vera, Victor Jair Morales, María Esteve

Spacing the administration interval of anti-TNF agents: a valid strategy for patients with inflammatory bowel disease?

Paola Francesca Torres Rodríguez, Laura Núñez, Ariadna Aguilar, Miriam Mañosa, Francisco Mesonero, Fiorella Cañete, Margalida Calafat, Cristina Fernandez, EDUARD CABRE, Antonio López-San Román, Eugeni Domenech Morral

USE OF ANTI-TNF AGENTS FOR PRIMARY PREVENTION OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE: A NATIONWIDE, REAL-LIFE STUDY. RESULTS FROM THE SPANISH ENEIDA REGISTRY

Eugeni Domenech Morral, Fiorella Cañete, Miriam Mañosa, Maria José Casanova, Ramiro C González Sueyro, Jesús Barrio, Fernando Bermejo, Pilar Nos, Eva Iglesias Flores, Esther García Planella, José Lázaro Pérez Calle, Raquel Vicente Lidón, Montserrat Rivero, Laura Ramos, Maribel Vera, Ruth De Francisco, Antonia Montserrat Tor

Item 1 - 8 / 8
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK